Atlas Trials

Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer

Clinical trial NCT02227940 · COMPLETED

Trial details

NCT number
NCT02227940
Sponsor
Roswell Park Cancer Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Malignant Solid NeoplasmALK PositiveMetastatic Pancreatic AdenocarcinomaStage III Pancreatic CancerStage IV Pancreatic Cancer
Start date
2015-01-08
Primary completion
2018-12-27
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.